Fidji Simo, OpenAI's CEO of Applications and the company's No. 2 executive, is stepping down from her full-time role as her ongoing medical leave has proven longer and more difficult than expected. She will transition to a part-time advisory position, the Wall Street Journal first reported on July 9, 2026.
The departure creates a significant leadership vacuum at OpenAI just as the company launches its most ambitious product cycle yet. For more breaking AI news and analysis of the industry's biggest leadership shifts, follow the coverage at AI Buzz Wire.
A Brief but Pivotal Tenure
Simo joined OpenAI in May 2025 as CEO of Applications, a newly created role reporting directly to Sam Altman. Her appointment consolidated the company's sprawling business and product operations under a single leader. COO Brad Lightcap, CFO Sarah Friar, and CPO Kevin Weil all began reporting to her, while Altman stepped back to focus on research, compute, and safety.
She came to OpenAI from Instacart, where she had been CEO since 2021 and guided the grocery delivery company through its 2023 initial public offering. Before that, she spent over a decade at Meta, including a stint running the Facebook app.
Her arrival at OpenAI coincided with a period of explosive growth. The company was most recently assigned an $852 billion valuation, making it one of the most valuable private companies in the world.
Health Struggles and Executive Exodus
Simo first disclosed her health issues in April 2026, when she announced she was taking medical leave for a relapse of a neuroimmune condition. That same memo also revealed that COO Brad Lightcap was shifting into a new special projects role, and CMO Kate Rouch was leaving the company to focus on cancer recovery.
CPO Kevin Weil departed shortly thereafter as well. In a staff note on Thursday, Simo wrote that her recovery had taken longer and been harder than anticipated, making a full-time return impractical.
Altman responded publicly on X, formerly Twitter: "i am really sad about this and very grateful for all fidji has done for openai, and even grateful for her friendship and who she is as a person. we all wish her the best for a speedy recovery. this sucks."
Timing Could Not Be More Critical
The announcement landed on one of the busiest news days in OpenAI's history. Earlier the same day, the company launched its new GPT-5.6 family of models, alongside ChatGPT Work, a new agent designed to handle multistep office tasks such as drafting documents, spreadsheets, and presentations.
Both product launches were framed by OpenAI as direct challenges to rival Anthropic.
Simo's departure leaves Altman searching for a successor at a moment of intensifying competition. She had been widely viewed as a likely candidate to take on even more responsibility once OpenAI went public, given her experience leading Instacart through its IPO process.
Her primary focus had been growing OpenAI's consumer business. However, ChatGPT's growth cooled late last year, missing internal revenue targets and pushing the company to lean harder into coding tools, an area where it continues to trail Anthropic.
Who Might Fill the Void
OpenAI's executive bench now appears thin for a company of its valuation. Beyond Altman, Lightcap, Friar, and co-founder Greg Brockman, the company's leadership includes Denise Dresser, who joined in December as chief revenue officer.
Dresser previously served as CEO of Slack and spent 14 years at Salesforce before that. Observers have speculated she could be in line for a more expansive role, though OpenAI has not indicated a succession plan.
The broader context is also worth noting. In April 2025, the same month Simo joined, OpenAI shortened its equity vesting cliff from the industry-standard 12 months to 6 months. By December, the company eliminated the cliff altogether for new hires, allowing equity to vest from day one. OpenAI was projected to spend $6 billion on stock-based compensation in 2025 alone, reflecting the ferocity of the AI talent war.
What Comes Next
Simo will remain on OpenAI's board of directors, a seat she has held since 2024. Her transition to an advisory role is expected to take effect immediately, though she will continue to provide strategic guidance.
The move underscores the human toll of leading through one of the most intense periods in technology history. For an industry obsessed with scaling at breakneck speed, the departure of one of its most prominent executives for health reasons serves as a stark reminder that even the most ambitious organizations are built by people with finite limits.
